This country profile provides an overview of Algeria’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
86%
Intestinal worms
N/A
Bilharzia
N/A
River blindness
N/A
4,614 people received treatment in Algeria in 2017 778 people did not receive treatment in in Algeria in 2017

Elephantiasis

Algeria does not require mass treatment for elephantiasis.

Blinding trachoma

Treatment coverage was not reported in 2016 and 86% in 2017.

People needing treatment
5,392
People receiving treatment
4,614

Intestinal worms

Algeria does not require mass treatment for intestinal worms.

Bilharzia

Algeria does not require mass treatment for bilharzia.

River blindness

Algeria does not require mass treatment for river blindness.